NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $579 | -100.0% | 35,853 | +38.4% | 0.01% | -71.4% |
| Q3 2022 | $1,968,000 | +578.6% | 25,908 | +519.1% | 0.02% | +600.0% |
| Q2 2022 | $290,000 | -86.5% | 4,185 | -85.4% | 0.00% | -75.0% |
| Q4 2021 | $2,152,000 | -62.0% | 28,671 | -41.2% | 0.01% | -65.7% |
| Q3 2021 | $5,660,000 | +94.5% | 48,726 | -0.7% | 0.04% | -59.8% |
| Q2 2020 | $2,910,000 | +556.9% | 49,088 | +646.1% | 0.09% | +200.0% |
| Q1 2020 | $443,000 | -69.5% | 6,579 | -66.2% | 0.03% | -58.0% |
| Q3 2019 | $1,453,000 | – | 19,436 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |